Stock Price & Analysis

Based on the provided data and current market conditions, here's a concise analysis of MMS stock:

Technical Analysis:

• Current price: $66.00 (as of Feb 21, 2025)
• RSI (14) at 26.88 indicates oversold conditions
• MACD shows bearish momentum with -2.50 reading
• Stock is trading below both 60-day SMA ($73.46) and 200-day SMA ($83.56)

Recent Price Action:

• Regular market percentage change: -1.14%
• Trading range: $64.53 - $66.92
• Volume: 680,601 shares

Fundamental Factors:

• Dividend yield: 1.72%
• Forward P/E: 17.59
• EV/EBITDA: 10.47
• Price/Sales: 0.77
• Price/Book: 2.27

Recent Developments:

• Department of Education awarded $6M contract for contact center support
• Insider activity shows positive sentiment with 7 purchases vs 2 sales in past 6 months
• Institutional investors show mixed activity: 189 adding positions, 174 reducing

Analyst Outlook:

• Price target: $90.00, implying 36.36% upside potential
• Current consensus: Buy rating

Recommendation: Buy

Rationale:

1. Stock is technically oversold, suggesting potential bounce
2. Strong insider buying indicates management confidence
3. Recent government contract wins demonstrate business stability
4. Significant upside potential to analyst target
5. Attractive valuation metrics relative to peers

Based on the available data and market analysis, here is the price prediction for MMS stock in 2025:

The MMS stock is expected to reach $82-85 by end of 2025, representing a potential upside of 24-29% from current price of $66. This projection is supported by:

1. Strong fundamentals with healthy margins (21.86% gross margin, 5.78% net margin) and solid ROE of 17.48%

2. Recent insider buying activity shows management confidence - CEO Bruce Caswell purchased 3,500 shares at $70.64 in December 2024, while multiple directors also made significant purchases in $70-72 range

3. Technical analysis indicates the stock is currently oversold with RSI at 26.88, suggesting potential for mean reversion rally

The stock has strong support around $63-65 range based on fibonacci levels, while resistance exists at $70-71. Breaking above this resistance could accelerate upward momentum.

The stock currently trades at reasonable valuation multiples (P/E: 18.66x, EV/EBITDA: 10.63x) compared to historical averages, providing room for multiple expansion as execution improves.

The S1 support level for MMS Stock is $65.35 ,The R1 resistant level for MMS Stock is $70.06.

As of the end of day on 2025-02-21, the price of MMS Stock was $66.

The target price for MMS Stock according to analyst rating is 90.00, with the highest price target at 90.00 and the lowest at 90.00. Analysts have a Moderate Buy rating on MMS Stock overall.

The market cap of MMS is $3.7B.

Based on the financial data and technical indicators, Maximus Inc (MMS) appears to be overvalued at current levels. The company's net income declined by 20.6% from $203.8M in FY2022 to $161.8M in FY2023, while ROE dropped significantly from 13.46% to 10.06%. Technical indicators show bearish signals with RSI-14 at 26.88 indicating oversold conditions, but MACD remains negative at -2.50 suggesting continued downward momentum. The stock is trading below all major moving averages (5,10,20,60,200-day SMAs), indicating a strong bearish trend. The current price of $66 represents poor value given the deteriorating fundamentals and technical weakness.

Maximus, Inc. is an operator of government health and human services programs and provider of technology solutions to governments. The Company operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment provides a variety of business process services (BPS), such as program administration, appeals and assessments, and related consulting work for United States state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions that help various United States federal government agencies, including program operations and management, clinical services, and technology solutions. The Outside the U.S. segment provides BPS for international governments and commercial clients. The services of this segment include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. It also delivers services in the United Kingdom.

Based on the available data and market analysis, here is the price prediction for MMS stock by 2030:

MMS stock is projected to reach $95-105 by 2030, representing a moderate upside from current levels around $66, driven by the company's strong government contract pipeline and operational improvements. The Department of Education's recent $6M contract award and over $1.2B in total government awards over the past year demonstrate MMS's solid federal business momentum.

The stock is currently technically oversold with an RSI of 29.5, suggesting potential for near-term price recovery. Strong insider buying activity with 7 purchases versus 2 sales in the past 6 months indicates management's confidence in the company's outlook.

The conservative price target factors in:

1. Steady government contract revenue growth
2. Margin expansion from operational efficiency initiatives
3. Mixed institutional investor sentiment with 189 adding positions and 174 reducing

MMS has a total of 39600 employees.